New Report Shows 28% Increase in YoY Funding for Rare Disease Drug Development in 2021

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes, a leading rare disease organization, in collaboration with DealForma, today previewed new data and analysis on the state of investment in rare disease drug development. The findings, to be published in their entirety in Global Genes’ NEXT 2022 report in February, indicate growing interest and...

Click to view original post